Glycopyrronium bromide


( Last Updated : November 30, 2012)
Generic Name:
Glycopyrronium bromide
Project Status:
Complete
Therapeutic Area:
Chronic obstructive pulmonary disease
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Call for patient/clinician input open:
Brand Name:
Seebri
Project Line:
Reimbursement Review
Project Number:
SR0300-000
Call for patient/clinician input closed:
NOC Status at Filing:
Post NOC

Details


Submission Type:
Initial
Indications:
Chronic Obstructive Pulmonary Disease (COPD), maintenance bronchodilator treatment
Recommendation Type:
List with criteria/condition
Final Recommendation: